Accéder au contenu
Merck
Toutes les photos(2)

Documents

HNDG3MAG-36K

Millipore

MILLIPLEX® Human Neurodegenerative Disease Magnetic Bead Panel 3 - Neuroscience Multiplex Assay

The analytes available for this multiplex kit are: BDNF, Cathepsin D, MPO, NCAM, PAI-1 (total), PDGF-AA, PDGF-AB/BB, RANTES, sICAM-1, sVCAM-1.

Synonyme(s) :

Human NeuroscienceProtein MultiplexAssay, Luminex® Human Neuroscience Panel, Millipore Human Neuroscience Immunoassay

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12161503
eCl@ss :
32161000
Nomenclature NACRES :
NA.84

Niveau de qualité

Espèces réactives

human

Fabricant/nom de marque

Milliplex®

assay range

accuracy: 108%
(RANTES)

accuracy: 108%
(sICAM-1)

accuracy: 111%
(Cathepsin D)

accuracy: 123%
(PDGF-AA)

accuracy: 137%
(PDGF-AB/BB)

standard curve range: 2-10,000 pg/mL
(RANTES)

standard curve range: 2.4-10,000 pg/mL
(BDNF)

standard curve range: 2.4-10,000 pg/mL
(PAI-1 (total))

standard curve range: 2.4-10,000 pg/mL
(PDGF-AA)

standard curve range: 24-100,000 pg/mL
(Cathepsin D)

standard curve range: 24-100,000 pg/mL
(MPO)

standard curve range: 24-100,000 pg/mL
(NCAM)

standard curve range: 24-100,000 pg/mL
(PDGF-AB/BB)

standard curve range: 24-100,000 pg/mL
(sICAM-1)

standard curve range: 61-250,000 pg/mL
(sVCAM-1)

Technique(s)

multiplexing: suitable

Méthode de détection

fluorometric (Luminex xMAP)

Conditions d'expédition

wet ice

Description générale

The MILLIPLEX® Human Neurodegenerative Bead Panel 3 (HNDG3MAG-36K) is to be used for the simultaneous quantification of the following 10 analytes in any combination: BDNF, Cathepsin D, MPO, NCAM, PAI-1 (total), PDGF-AA, PDGF-AB/BB, RANTES, sICAM-1, and sVCAM-1. This kit may be used for the analysis of all above analytes in human serum, plasma, and cerebrospinal fluid samples.

Panel Type: Neuroscience

Spécificité

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Application

  • Analytes: BDNF, Cathepsin D, MPO, NCAM, PAI-1 (total), PDGF-AA, PDGF-AB/BB, RANTES, sICAM-1, sVCAM-1
  • Recommended Sample type: Serum, plasma, or CSF
  • Recommended Sample dilution: 1:100 diluted serum/plasma or neat CSF
  • Assay Run Time: Overnight
  • Research Category: Neuroscience
  • Research Subcategory: Category Alzheimer′s Disease Nervous System Neurodegenerative Diseases

Caractéristiques et avantages

Design your multiplex kit by choosing available analytes within this panel.

Conditionnement

Everything you need in a single kit.

Stockage et stabilité

Recommended storage for kit components is 2 - 8°C.

Autres remarques

Sensitivity: See kit protocol for individual sensitvities

Informations légales

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2

Organes cibles

Respiratory Tract

Code de la classe de stockage

10 - Combustible liquids


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Maren S Fragala et al.
Journal of strength and conditioning research, 28(8), 2079-2087 (2014-05-17)
Aerobic exercise has been shown to counteract age-related neurological decrements that are associated with cognitive and physical impairments. However, the effects of resistance exercise on cognition, reaction, and neurotrophins are largely unknown. We examined changes in spatial awareness, visual and
Carolina Segura et al.
Frontiers in neurology, 11, 656-656 (2020-08-15)
Rationale: The optimal modality, intensity, duration, frequency, and dose-response of exercise as a therapy for Parkinson's Disease (PD) are insufficiently understood. Objective: To assess the impact of a high-intensity tandem bicycle program on clinical severity, biomarkers, and functional MRI (fMRI)
Kiyokazu Atake et al.
Frontiers in psychiatry, 9, 232-232 (2018-06-14)
Background: Cognitive impairment in schizophrenia can result in considerable difficulty in performing functions of daily life or social rehabilitation. Cognitive impairment in schizophrenia is related to various factors, such as the psychotic severity, aging, medication, and brain-derived neurotrophic factor (BDNF).
Rita Capirossi et al.
International journal of molecular sciences, 21(23) (2020-12-03)
Although, biomarkers are regarded as an important tool for monitoring injury severity and treatment efficacy, and for predicting clinical evolution in many neurological diseases and disorders including spinal cord injury, there is still a lack of reliable biomarkers for the
Meike Dirks et al.
Transplant immunology, 58, 101248-101248 (2019-11-02)
While acute neurotoxic side effects of calcineurin inhibitors (CNI) are well-known, data upon long-term effects on brain structure and function are sparse. We hypothesize that long-term CNI therapy affects the neuroimmune system, thereby, increasing the risk of neurodegeneration. Here, we

Contenu apparenté

Multiplex detection of Alzheimer's biomarkers with MILLIPLEX® Human Amyloid Beta and Tau Magnetic Bead Panel aids research.

Neuroscience multiplex assays measure biomarkers to understand neurodegenerative diseases, disorders, and neuropeptide signaling.

Find immunoassays to explore neuroimmunology and neuroinflammation cytokines and neurodegenerative disease biomarkers.

Trouvez des immunoessais pour explorer les cytokines impliquées dans la neuroimmunologie et la neuroinflammation, ainsi que les biomarqueurs des maladies neurodégénératives.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique